113
Views
0
CrossRef citations to date
0
Altmetric
General Medicine

Predictive Value of the Prothrombin Time-International Normalized Ratio to Albumin Ratio in the Prognosis of Patients with Hepatitis B Virus-Related Acute-on-Chronic Liver Failure

ORCID Icon, ORCID Icon, , , & ORCID Icon
Pages 4565-4572 | Received 09 Aug 2023, Accepted 28 Sep 2023, Published online: 06 Oct 2023

References

  • Moreau R, Gao B, Papp M, Bañares R, Kamath PS. Acute-on-chronic liver failure: a distinct clinical syndrome. J Hepatol. 2021;75(1):S27–S35. doi:10.1016/j.jhep.2020.11.047
  • Wang H, Men P, Xiao Y, et al. Hepatitis B infection in the general population of China: a systematic review and meta-analysis. BMC Infect Dis. 2019;19(1):811. doi:10.1186/s12879-019-4428-y
  • Sarin SK, Choudhury A, Sharma MK, et al. Acute-on-chronic liver failure: consensus recommendations of the Asian Pacific association for the study of the liver (APASL): an update. Hepatol Int. 2019;13(4):353–390. doi:10.1007/s12072-019-09946-3
  • Zhao RH, Shi Y, Zhao H, Wu W, Sheng JF. Acute-on-chronic liver failure in chronic hepatitis B: an update. Expert Rev Gastroenterol Hepatol. 2018;12(4):341–350. doi:10.1080/17474124.2018.1426459
  • Kumar R, Mehta G, Jalan R. Acute-on-chronic liver failure. Clin Med. 2020;20(5):501–504. doi:10.7861/clinmed.2020-0631
  • Haruki K, Shiba H, Saito N, et al. Risk stratification using a novel liver functional reserve score of combination prothrombin time-international normalized ratio to albumin ratio and albumin in patients with hepatocellular carcinoma. Surgery. 2018;164(3):404–410. doi:10.1016/j.surg.2018.02.022
  • Wu T, Li J, Shao L, et al. Development of diagnostic criteria and a prognostic score for hepatitis B virus-related acute-on-chronic liver failure. Gut. 2018;67(12):2181–2191. doi:10.1136/gutjnl-2017-314641
  • Kamath PS, Wiesner RH, Malinchoc M, et al. A model to predict survival in patients with end-stage liver disease. Hepatology. 2001;33(2):464–470. doi:10.1053/jhep.2001.22172
  • Biggins SW, Kim WR, Terrault NA, et al. Evidence-based incorporation of serum sodium concentration into MELD. Gastroenterology. 2006;130(6):1652–1660. doi:10.1053/j.gastro.2006.02.010
  • Pugh RN, Murray-Lyon IM, Dawson JL, Pietroni MC, Williams R. Transection of the oesophagus for bleeding oesophageal varices. Br J Surg. 1973;60(8):646–649. doi:10.1002/bjs.1800600817
  • Clària J, Stauber RE, Coenraad MJ, et al. Systemic inflammation in decompensated cirrhosis: characterization and role in acute-on-chronic liver failure. Hepatology. 2016;64(4):1249–1264. doi:10.1002/hep.28740
  • Laleman W, Claria J, Van der Merwe S, Moreau R, Trebicka J. Systemic Inflammation and Acute-on-Chronic Liver Failure: too Much, Not Enough. Can J Gastroenterol Hepatol. 2018;2018:1027152. doi:10.1155/2018/1027152
  • Casulleras M, Zhang IW, López-Vicario C, Clària J. Leukocytes, Systemic Inflammation and Immunopathology in Acute-on-Chronic Liver Failure. Cells. 2020;9(12):2632. doi:10.3390/cells9122632
  • Wang S, Ding S, Luo H, Chai X. International Normalized Ratio to Albumin Ratio (PTAR): an Objective Risk Stratification Tool in Patients with Sepsis. Int J Gen Med. 2021;14:1829–1841. doi:10.2147/IJGM.S305085
  • S S. Assessment of INR to Albumin Ratio in Predicting Outcome During Hospital Stay in Patients with Cirrhosis of Liver with Sepsis. J Assoc Physicians India. 2022;70(4):11–12.
  • Gao F, Cai MX, Lin MT, et al. Prognostic value of international normalized ratio to albumin ratio among critically ill patients with cirrhosis. Eur J Gastroenterol Hepatol. 2019;31(7):824–831. doi:10.1097/MEG.0000000000001339
  • Cai M, Han Z, He X, Zhang J. Usefulness of International Normalized Ratio to Albumin Ratio for Evaluation of Mortality in Hepatitis B Virus-Associated Decompensated Cirrhosis. Biomed Res Int. 2021;2021:6664574. doi:10.1155/2021/6664574
  • Quinlan GJ, Martin GS, Evans TW. Albumin: biochemical properties and therapeutic potential. Hepatology. 2005;41(6):1211–1219. doi:10.1002/hep.20720
  • Arroyo V, Clària J. Acute-on-Chronic Liver Failure, Human Serum Albumin, and Immune Modulation: the Beginning of an Exciting Adventure. Clin Gastroenterol Hepatol. 2018;16(5):633–636. doi:10.1016/j.cgh.2017.12.008
  • China L, Maini A, Skene SS, et al. Albumin Counteracts Immune-Suppressive Effects of Lipid Mediators in Patients With Advanced Liver Disease. Clin Gastroenterol Hepatol. 2018;16(5):738–747.e7. doi:10.1016/j.cgh.2017.08.027
  • Bernardi M, Maggioli C, Zaccherini G. Human albumin in the management of complications of liver cirrhosis. Crit Care. 2012;16(2):211. doi:10.1186/cc11218
  • Northup PG, Caldwell SH. Coagulation in liver disease: a guide for the clinician. Clin Gastroenterol Hepatol. 2013;11(9):1064–1074. doi:10.1016/j.cgh.2013.02.026
  • Porte RJ, Lisman T, Tripodi A, Caldwell SH, Trotter JF; Coagulation in Liver Disease Study Group. The International Normalized Ratio (INR) in the MELD score: problems and solutions. Am J Transplant. 2010;10(6):1349–1353. doi:10.1111/j.1600-6143.2010.03064.x